Banner Beats Biogen On Tecfidera Technicality

Hybrid 505(b)(2) Product Holds Tentative US Approval

 
• By Dean Rudge
  
Gavels
A US Court Appeals has ruled in favor of Banner Life Sciences • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Legal & IP

More from Generics Bulletin